3 results
Approved WMOCompleted
To confirm the safety of the Articulinx ICC by evaluating device- and procedure relates adverse events.
Not approvedWill not start
To compare the EPOS guideline with the free choice treatment of the GP for acute rhinosinusitis in general practice.
Approved WMORecruiting
Primary:- To test whether bevacizumab added to a backbone chemotherapy regimen (temozolomide or irinotecan-temozolomide or topotecan-temozolomide) demonstrates activity in children with relapsed or refractory neuroblastoma- To test whether the…